In nasopharyngeal carcinoma CNE2 cells, EGCG upregulates miR-34a, which directly targets Notch1, thereby suppressing cancer cell proliferation, migration, and invasion (Li B. B. et al., 2017). This evidence concerns the gene NOTCH1 and cancer.